Posted by Michael Wonder on 07 Sep 2022
EMA refused rolling review of SK Bioscience's COVID-19 vaccine
7 September 2022 - The EMA refused a rolling review of SK Bioscience's COVID-19 vaccine, SKYCovine, due to “changing pandemic conditions,” a senior official at SK Bioscience said.
The SK Bioscience official said the company plans to submit the vaccine's data to the WHO to earn Emergency Use listing and vowed to win approval from regulatory agencies worldwide as soon as possible.
